Analytical Data
-
基因名
ATP7a
- Application
-
别名
ATP7a；MC1；MNK；Copper-transporting ATPase 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q04656
-
表达区间
1406-1500aa
-
氨基酸序列
FLKLYRKPTYESYELPARSQIGQKSPSEISVHVGIDDTSRNSPKLGLLDR IVNYSRASINSLLSDKRSLNSVVTSEPDKHSLLVGDFREDDDTAL
-
分子量
36 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human ARID4A Protein，His
Cat：PA2000-5594
Recombinant Human PBX3 Protein，His
Cat：PAX2000-10140
Protein Description
ATP7A is a gene that encodes a copper-transporting ATPase, which is crucial for maintaining copper homeostasis in the body. Mutations in the ATP7A gene lead to Menkes disease, a severe neurodegenerative disorder characterized by copper deficiency resulting in developmental delays, neurological impairments, and impaired connective tissue function. The study of ATP7A recombinant proteins is fundamental for understanding the molecular mechanisms underlying copper transport and its role in cellular metabolism. By expressing and purifying ATP7A recombinant proteins, researchers can investigate the enzyme's functional properties, its interaction with various ligands, and the impact of specific mutations on its activity. Characterizing these proteins provides insights into the pathophysiology of Menkes disease, aids in the identification of potential therapeutic targets, and enhances our understanding of copper-related disorders. Additionally, studying ATP7A may help develop novel strategies for gene therapy and pharmacological interventions aimed at correcting copper imbalances in affected individuals. Overall, the investigation of ATP7A recombinant proteins is crucial for both basic research and the development of clinical applications related to copper homeostasis and its associated diseases.
